More access beyond metro elite patients: With lower pricing, treatment may gradually become more realistic for middle-income Indian families too
Yes glutathione IV is considered safe when administered under dermatologist supervision
I include a patient-centered switching strategy (e.g., from dulaglutide to semaglutide or tirzepatide), practical integration of nutrition and exercise, and real-world barriers such as cost, access, and injection hesitancy
The message is simple: when the scale changes, thyroid management may need a fresh look
The generation of seizures in peri-tumoral neuronal networks inevitably disrupts ionic homeostasis
Patients should not discontinue or alter thyroid hormone replacement when using tirzepatide, and close endocrinologic supervision remains essential